SE0102184D0 - New subject-matter - Google Patents

New subject-matter

Info

Publication number
SE0102184D0
SE0102184D0 SE0102184A SE0102184A SE0102184D0 SE 0102184 D0 SE0102184 D0 SE 0102184D0 SE 0102184 A SE0102184 A SE 0102184A SE 0102184 A SE0102184 A SE 0102184A SE 0102184 D0 SE0102184 D0 SE 0102184D0
Authority
SE
Sweden
Prior art keywords
subject matter
new subject
mesotocin
oxytocin
tri
Prior art date
Application number
SE0102184A
Other languages
English (en)
Swedish (sv)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Maria Petersson
Original Assignee
Uvnaes Moberg Kerstin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uvnaes Moberg Kerstin filed Critical Uvnaes Moberg Kerstin
Priority to SE0102184A priority Critical patent/SE0102184D0/xx
Publication of SE0102184D0 publication Critical patent/SE0102184D0/xx
Priority to DE60224280T priority patent/DE60224280D1/de
Priority to AT02739051T priority patent/ATE382054T1/de
Priority to US10/481,623 priority patent/US7714105B2/en
Priority to EP02739051A priority patent/EP1409518B1/de
Priority to PCT/SE2002/001207 priority patent/WO2002102832A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE0102184A 2001-06-19 2001-06-19 New subject-matter SE0102184D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0102184A SE0102184D0 (sv) 2001-06-19 2001-06-19 New subject-matter
DE60224280T DE60224280D1 (de) 2001-06-19 2002-06-19 Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
AT02739051T ATE382054T1 (de) 2001-06-19 2002-06-19 Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
US10/481,623 US7714105B2 (en) 2001-06-19 2002-06-19 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
EP02739051A EP1409518B1 (de) 2001-06-19 2002-06-19 Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
PCT/SE2002/001207 WO2002102832A1 (en) 2001-06-19 2002-06-19 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102184A SE0102184D0 (sv) 2001-06-19 2001-06-19 New subject-matter

Publications (1)

Publication Number Publication Date
SE0102184D0 true SE0102184D0 (sv) 2001-06-19

Family

ID=20284539

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102184A SE0102184D0 (sv) 2001-06-19 2001-06-19 New subject-matter

Country Status (6)

Country Link
US (1) US7714105B2 (de)
EP (1) EP1409518B1 (de)
AT (1) ATE382054T1 (de)
DE (1) DE60224280D1 (de)
SE (1) SE0102184D0 (de)
WO (1) WO2002102832A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4654418B2 (ja) 2004-03-31 2011-03-23 独立行政法人産業技術総合研究所 上皮系細胞増殖促進剤
WO2011027060A2 (fr) 2009-09-04 2011-03-10 Centre National De La Recherche Scientifique - Crns - Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
SG11201705591PA (en) 2015-01-07 2017-08-30 Trigemina Inc Magnesium-containing oxytocin formulations and methods of use
HUE070412T2 (hu) 2016-04-12 2025-06-28 Tonix Pharma Ltd Magnézium tartalmú oxitocin készítmények és alkamazási eljárásaik
JP6527996B2 (ja) * 2017-09-12 2019-06-12 株式会社 金冠堂 Fgf活性に影響を与えるジペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
EP0146113A3 (de) 1983-12-15 1987-08-19 Dieter Aderhold Wirkstoff und therapeutisches Mittel zur Behandlung von Fehlfunktionen des Diencephalon, von Nervenerkrankungen und Erkrankungen der Haut
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
SE9803271D0 (sv) 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for well-being

Also Published As

Publication number Publication date
EP1409518B1 (de) 2007-12-26
DE60224280D1 (de) 2008-02-07
ATE382054T1 (de) 2008-01-15
EP1409518A1 (de) 2004-04-21
US20040259805A1 (en) 2004-12-23
US7714105B2 (en) 2010-05-11
WO2002102832A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1108547T1 (el) Αναλογα σωματοστατινης
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
TW200505875A (en) Novel compounds
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
EP1423137A4 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
PL374080A1 (en) Processes for the preparation of fibrinogen
PL1622939T3 (pl) Aktywne warianty białka wiążącego IL-18 i ich medyczne zastosowania
DE50113345D1 (de) Arginin-mimetika als faktor xa-inhibitoren
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
PT1290160E (pt) Polipeptideos pellino humanos
SE0102184D0 (sv) New subject-matter
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
BRPI0408446A (pt) tablete de limpeza
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
SE0101220D0 (sv) New use
WO2005035746A3 (en) Medical use of tbk-1 or of inhibitors thereof
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
DK1626726T3 (da) Anvendelse af lornoxicam eller lornoxicam-analoger
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato